Research Projects - Leiomyosarcoma.info
This page lists research projects supported by the National Leiomyosarcoma Foundation (NLMSF) and other organizations, including SPORE initiatives, multi‑omic liquid biopsy development, circulating tumor DNA (ctDNA) studies, and collaborations with institutes such as the Broad Institute, Stanford University, and the Sarcoma Alliance Through Research and Collaboration (SARC).
This page lists research projects supported by the National Leiomyosarcoma Foundation (NLMSF) and other organizations, including SPORE initiatives, multi‑omic liquid biopsy development, circulating tumor DNA (ctDNA) studies, and collaborations with institutes such as the Broad Institute, Stanford University, and the Sarcoma Alliance Through Research and Collaboration (SARC).
The projects summarized here represent a coordinated effort to accelerate understanding of leiomyosarcoma biology, identify actionable genomic vulnerabilities, develop novel diagnostic assays, and translate findings into clinical trials. They showcase the impact of philanthropic and institutional funding on propelling research for a rare but aggressive sarcoma.
Bizonyítékszint: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Kapcsolódó jelek
- First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine—A Systematic Review
- Leiomyosarcoma
- Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
- Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
- Immunotherapy-based salvage therapy in advanced soft tissue sarcoma after first-line chemotherapy: a retrospective single-center analysis with emphasis on undifferentiated pleomorphic sarcoma